First Quadrant’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-9,000
Closed -$179K 806
2014
Q3
$179K Sell
9,000
-5,900
-40% -$124K ﹤0.01% 564
2014
Q2
$340K Sell
14,900
-48,100
-76% -$856K 0.01% 508
2014
Q1
$810K Hold
63,000
0.02% 396
2013
Q4
$859K Buy
63,000
+50,200
+392% +$599K 0.02% 399
2013
Q3
$142K Buy
+12,800
New +$127K ﹤0.01% 578

Other funds holding RGEN

First Quadrant's RGEN Position: Q4 2014 in Review

First Quadrant sold out of Repligen (RGEN) in Q4 2014, closing a stake of 9,000 shares — an estimated $179K sold.

First Quadrant first reported a position in RGEN in Q3 2013 and held it in 5 quarters. The position peaked at $859K in Q4 2013. 164 funds tracked by Wall St. Rank hold RGEN as of Q4 2014.

  • First Quadrant reported no remaining Repligen position as of Q4 2014 after selling out during the quarter.
  • First Quadrant sold 9,000 Repligen shares in Q4 2014, an estimated $179K.
  • First Quadrant first reported a position in Repligen in Q3 2013 and held it in 5 quarters.
  • First Quadrant's Repligen position peaked at $859K in Q4 2013.
  • 164 funds tracked by Wall St. Rank held Repligen as of Q4 2014.

Based on First Quadrant's 13F filing for Q4 2014, filed 27 Jan 2015.